ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,073 | -8.6% | 625 | -0.8% | 0.01% | +25.0% |
| Q2 2023 | $42,740 | +25.5% | 630 | +0.3% | 0.01% | +14.3% |
| Q1 2023 | $34,069 | -6.7% | 628 | +3.1% | 0.01% | -12.5% |
| Q4 2022 | $36,516 | +30.4% | 609 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $28,000 | -17.6% | 609 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $34,000 | -20.9% | 609 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $43,000 | +7.5% | 609 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $40,000 | -13.0% | 609 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $46,000 | -4.2% | 609 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $48,000 | -4.0% | 609 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $50,000 | -2.0% | 609 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $51,000 | +27.5% | 609 | 0.0% | 0.01% | +7.7% |
| Q3 2020 | $40,000 | +5.3% | 609 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $38,000 | – | 609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 396,670 | $27,477,000 | 7.28% |
| Endurant Capital Management LP | 163,092 | $11,297,000 | 3.56% |
| REINHART PARTNERS, LLC. | 656,158 | $45,452,000 | 3.34% |
| RK Capital | 117,590 | $8,145,000 | 3.05% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 27,150 | $1,881,000 | 2.23% |
| Wolf Group Capital Advisors | 47,461 | $3,288,000 | 2.16% |
| Copeland Capital Management, LLC | 631,346 | $43,734,000 | 1.92% |
| Advantage Alpha Capital Partners LP | 100,722 | $6,977,000 | 1.88% |
| Rock Springs Capital Management LP | 815,000 | $56,455,000 | 1.78% |
| Kalos Management, Inc. | 61,180 | $4,237,000 | 1.54% |